The role of compression therapy after endovenous laser ablation (EVLA) – review

Abstract

Introduction: Chronic venous disease (CVD) is a rising problem in Western countries. There are several stages of CVD that can be treated in different ways. One of the methods of treating varicosity, Stage C2 of CVD, is through endovenous laser ablation (EVLA). While still being developed, this method is popular due to its short operation time, less bleeding, quick recovery, and lack of surgical scars. Compression therapy with compression stockings has been widely used as a conservative treatment of early-stage CVD and it's also used EVLA. However, there are no strong recommendations to use compression therapy after this kind of surgery. Aim and method: The aim of this paper is to review existing knowledge about the benefits of compression therapy and to identify a recommended time period for its use after EVLA. The databases used in the review were Pubmed and Cochrane. Results: Studies focusing on compression therapy for varicose veins after EVLA have questioned the prolonged use of compression therapy, as it brings no additional benefits and might be difficult for patients to adhere to. The existing studies recommended a period no longer than 1–2 weeks. No significant differences were found in reoccurrence rate or return to normal activities between compression and non-compression groups. It has been proven that compression therapy significantly reduces postoperative pain and the consumption of analgesics. Discussion: Compression therapy seems to be a safe option for low pain management. There is a need for further research involving the impact of compression therapy after EVLA, especially in group of low energy settings, as the results of treatment are promising.